Delivery Order SPE2DB25D9320-SPE2DB25FWFAH
- Not listed
- The Defense Logistics Agency awarded a $32,499.90 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, issued on September 18, 2025, is set to be completed by October 9, 2025, and will be performed at the contractor's Park Ridge facility. The award represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a $16,249.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Stelara 90 mg/ml syringes, with an ultimate completion date of August 28, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents a single transaction under the company's larger Indefinite Delivery Contract with DLA, valued at...
- The Defense Logistics Agency (DLA) awarded a $48,749.85 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The contract, awarded on June 30, 2025, with an ultimate completion date of July 22, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, valued at $16,249.95, was awarded on September 2, 2025, with an ultimate completion date of September 23, 2025. The contract does not utilize a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. The contract, awarded on August 19, 2025, with an ultimate completion date of September 10, 2025, operates under a firm fixed-price arrangement with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, carries no set-aside designation. The award was issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $32,499.90 for Stelara 90 mg/ml syringes. This firm fixed-price delivery order, awarded on August 14, 2025, with an ultimate completion date of September 5, 2025, was issued without a set-aside designation. The award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the...
- The Defense Logistics Agency awarded a delivery order valued at $8,220.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The contract is firm fixed price with an ultimate completion date of May 28, 2025, and was awarded on May 6, 2025. This delivery order was issued without a set-aside designation, leveraging the vendor's competitive positioning in the federal pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $97,499.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, issued on July 28, 2025, with an ultimate completion date of August 18, 2025, represents a tactical purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at $500...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, carries no set-aside designation. The award represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- SPE2DB25D9320Indefinite Delivery Contract
- SPE2DB25D9320-SPE2DB25FWFAHDelivery Order
The Defense Logistics Agency awarded a $8,220.68 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The award, issued on April 23, 2025, with an ultimate completion date of May 14, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA valued at approximately $500 million and valid through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in government procurement markets. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare systems. Stelara, an injectable biologic medication, represents the type of specialty pharmaceutical product the company routinely supplies through its DLA contract portfolio, which encompasses treatments across multiple therapeutic areas from oncology to immunology to support the medical needs of military health facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 4/23/25 |